Skip to main content

Together we are beating cancer

Donate now

Lymphoma

Showing 12 out of 88 results
People at a party wearing party hats

In this third and final article in this special series about our PPI project ‘How can we share research together? A co-creation project to make scientific research more accessible’ we hear from one of the patient representatives who took part in the project, Holly Spencer. Here Holly reflects on her diagnosis, her interest in patient and public involvement and her experience of being part of this project. In this third and final article in this special series about our PPI project ‘How can we share research together? A co-creation project to make scientific research more accessible’ we hear from one of the patient representatives who took part in the project, Holly Spencer. Here Holly reflects on her diagnosis, her interest in patient and public involvement and her experience of being part of this project.

by Holly Spencer | Personal stories | 11 June 2024

11 June 2024

This entry is part 3 of 3 in the series How can we share research together?
That Cancer Conversation in a white speech bubble with a dark blue background

In another episode of That Cancer Conversation, Sophie speaks to Shaumya about being diagnosed with Hodgkin Lymphoma at 18. In another episode of That Cancer Conversation, Sophie speaks to Shaumya about being diagnosed with Hodgkin Lymphoma at 18.

by Cancer Research UK | Podcast | 26 April 2024

26 April 2024

This entry is part 16 of 21 in the series That Cancer Conversation
Senedd Cymru, or the Welsh Parliament.

Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change. Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change.

by Tim Gunn | News | 8 June 2023

8 June 2023

Lab equipment at our Experimental Cancer Medicine Centre in Southampton
  • Science & Technology
  • Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

by Tim Gunn | In depth | 18 April 2023

18 April 2023

Fatimah, 19, near her home, and Adam, 23, on holiday. They were both diagnosed with cancer in their mid-teens.

For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer. For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer.

by Tom Bourton | Personal stories | 6 April 2023

6 April 2023

Lymphoma cells

Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England Ibrutinib, a drug used to treat Waldenstrom’s macroglobulinaemia, is not being recommended by the National Institute for Health and Care Excellence in England

by In collaboration with PA Media Group | News | 23 May 2022

23 May 2022

Lung cancer cells

Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected. Three new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, two for non small cell lung cancer and one for Hodgkin lymphoma, but a fourth has been rejected.

by Harry Jenkins | News | 11 November 2021

11 November 2021

antibodies

How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma. How scientific expertise, funding and entrepreneurship came together for the development of an antibody-drug conjugate targeting lymphoma.

by Cancer Research UK | Research Feature | 2 July 2021

2 July 2021